SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.

scientific article

SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RADONC.2016.08.015
P698PubMed publication ID27600155

P50authorErik HolmbergQ41783678
P2093author name stringRolf Lewensohn
Jan Nyman
Ingmar Lax
Signe Friesland
Bengt Bergman
Per Bergström
Andreas Hallqvist
Jo-Åsmund Lund
Odd-Terje Brustugun
P433issue1
P921main subjectadaptive radiation therapyQ180507
P304page(s)1-8
P577publication date2016-09-03
P1433published inRadiotherapy and OncologyQ14251029
P1476titleSPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.
P478volume121

Reverse relations

cites work (P2860)
Q90296646A Population-based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-small Cell Lung Cancer Patients
Q90415320A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER
Q48312990A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC.
Q59799824A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer
Q38790915A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer
Q64325572Advances in proton therapy in lung cancer
Q91632005CHISELing a path forward in the treatment of early-stage non-small-cell lung cancer
Q88813122Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years
Q99240991Chest wall toxicity after stereotactic radiation in early lung cancer: a systematic review
Q57279966Clinical trials involving carbon-ion radiation therapy and the path forward
Q58804834Combining immunotherapy with radiation therapy in thoracic oncology
Q47446694Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
Q43191730Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
Q89869712Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin
Q60908706Developments in Stereotactic Body Radiotherapy
Q36729311Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis
Q55001587Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer.
Q89572724Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies
Q102067109Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway
Q30238797Influence of dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer
Q48128980Managing an Older Adult with Cancer: Considerations for Radiation Oncologists
Q61804649Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes
Q92461774Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer
Q35880933Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer.
Q96305367Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments
Q64277127Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non-small-cell lung cancer
Q56528378Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?
Q94465235Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
Q91830232Prognostic Role Of Computed Tomography Textural Features In Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy
Q89996520Prognostic impact of solid tumor component diameter in early-stage non-small cell lung carcinoma treated with intensity-modulated fractionated radiotherapy: a retrospective analysis impact of solid tumor component diameter in NSCLC treated with IMRT
Q60938857Promising Clinical Outcome With Long Term Follow-Up After Body Gamma Knife Stereotactic Radiosurgery for Patients With Early Stage Non-small Cell Lung Cancer
Q55038620Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't!
Q47718099Radiobiological Optimization in Lung Stereotactic Body Radiation Therapy: Are We Ready to Apply Radiobiological Models?
Q42109226Radiotherapy for Oligometastatic Lung Cancer
Q94592974Radiotherapy in Lung Cancer: Current and Future Role
Q58804832Reirradiation for locoregionally recurrent non-small cell lung cancer
Q47115640Research in imaging/biomarkers for precision medicine in lung cancer: National Cancer Institute funding opportunities
Q64106509Research of Biological Dose Conversion Platform Based on a Modified Linear Quadratic Model
Q48282380Rethink radiotherapy - BIGART 2017.
Q48233447Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
Q91684310SABR versus conventional fractionation regimens in NSCLC
Q95473369SABR versus conventional fractionation regimens in NSCLC
Q89932945Single-lung stereotactic body radiotherapy: A case report and discussion of therapeutic challenges
Q53822924Standard of care in high-dose radiotherapy for localized non-small cell lung cancer.
Q98289160Stereotactic ablative body radiotherapy versus conventionally fractionated radiotherapy for early stage large cell neuroendocrine carcinoma of the lung
Q91631990Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
Q57172947Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances
Q89005809Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC)
Q55282076Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives.
Q57177641Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions
Q60912983Stereotactic body radiation therapy for non-small cell lung cancer: A review
Q91875040Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer
Q64096283Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
Q61804651Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer
Q89870886Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer
Q90591596Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer
Q28085744Stereotactic radiotherapy for early lung cancer: Evidence-based approach and future directions
Q35824255Stereotactic radiotherapy for early stage non-small cell lung cancer
Q47275269Survival of localized NSCLC patients without active treatment or treated with SBRT.
Q38962875Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?

Search more.